Maria-Jacobi-Gasse 1, Media Quarter Marx 3.2, A-1030 Vienna | office@inits.at  | Phone: +43 1 – 715 72 67

START:IP Portfolio

Technologies for START:IP 2021
Health Care/Biotech/Digital Health

Naturally Derived Blood Clotting Agent

Blood clotting, or hemostatic, agents are a medical necessity to prevent bleeding after injury or during surgery. Currently available hemostatic agents are limited in their utility (e.g. poor shelf-life, toxic side-effects) or come from animal sources. This hemostatic agent is derived from a biopolymer found in fungi. It has exceptional blood-clotting activity, is antimicrobial, and biocompatible.

Read More »
Energy/Environment/Sustainability

Recycling Carbon Dioxide into Methanol

Reduced carbon emissions are desperately needed to prevent global warming. Carbon dioxide (CO2) waste from industrial flue gas can be recycled, by reacting on a chemical catalyst, to produce methanol, but other compounds in flue gas interfere with this reaction. These researchers have developed a catalyst that reacts with CO2, but not the contaminants, to produce methanol.

Read More »
IT/Security/Fintec/Insurtech etc.

Faster Computing in Memory

It is becoming more difficult to increase computing speed, but a solution to this that is gaining great interest is computing “in-memory” – processing within memory arrays rather than separate processing arrays. Even within in-memory computing, new solutions are required to process faster. This technology is a way to perform a classic computer operation (XOR) faster in-memory.

Read More »
Health Care/Biotech/Digital Health

Cell-based test for kinase inhibitors

Many cancers are driven by hyperactive cell signaling proteins, known as kinases. Drugs that inhibit these kinases make attractive anticancer therapies. A bottleneck for kinase inhibitor development is being able to test whether inhibition is effective, for which current testing methods are inadequate. This method directly measures kinase activity in live cells, to better assess potential kinase inhibitors.

Read More »
Health Care/Biotech/Digital Health

Cellular delivery for gene therapy

With modern gene editing technology, it is now possible to precisely repair genes that cause human disease. However, there is a bottleneck in getting the required gene editing components into the cells that are affected by the faulty gene. This technology solves this problem, creating a cellular delivery system for these gene editing tools.

Read More »
Health Care/Biotech/Digital Health

Skin Lesion Detection and Diagnosis

Skin cancers are incredibly common, but they are difficult to detect at an early stage. We all have odd moles and bumps on our skin, but these are examined by a doctor maybe once a year, at most. With this app, patients can self-monitor their skin lesions and get an accurate prediction of cancer risk.

Read More »
Health Care/Biotech/Digital Health

Streamlined Healthcare Data Management Software

Any one patient is linked to a lot of data – from their personal details, medical history, reports from lab tests, medication or surgery details, data from wearables, the list goes on and becomes more complicated. This software makes the complicated simple, collecting and consolidating medical data into one easy and usable platform.

Read More »
Health Care/Biotech/Digital Health

Detection of CAR-T Cells

CAR-T cell therapy is an exciting new form of cancer therapy that uses the patient’s own immune system to attack cancer cells. However, CAR-T cells are difficult to monitor in a patient, preventing an assessment of whether they are working or not. These researchers have developed an easy solution to study leukaemia- and lymphoma-specific CAR-T cells.

Read More »
IT/Security/Fintec/Insurtech etc.

The Pan-European Emergency App

Access to emergency services can mean the difference between life and death, but efficient access to help is more than dialing 112. What if you couldn’t speak the language, don’t know where you are, or have a hearing disability? This app solves these issues by automatically sending your location to 112 services, works across borders, and supports other means of

Read More »
Health Care/Biotech/Digital Health

Novel treatment for leukaemia

Acute Myeloid Leukaemia (AML) is one of the deadliest blood cancers, with a 5-year survival rate of less than 25%. There has been no dramatic improvement in AML treatments since the 1970s, but this group of researchers has identified a druggable Achille’s Heel, specific to AML and other blood cancers.

Read More »
Shortlist:

(Bookmark technologies to show them here)

No Bookmarks

Persönliches Profil